The effects of tibolone on mood and libido

Menopause

Volumn 9, Issue 3, 2002, Pages 162-170

  Davis, Susan R ^a  

^a NONE   (Australia)

Author keywords

Female androgen insufficiency; Tibolone

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; APOLIPOPROTEIN A1; BETA ENDORPHIN; BETA LIPOTROPIN; CONJUGATED ESTROGEN; ESTRADIOL; ESTRADIOL BENZOATE; ESTRADIOL VALERATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; MEDROGESTONE; NORGESTREL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TESTOSTERONE PROPIONATE; TIBOLONE; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CLINICAL TRIAL; COGNITION; DRUG MECHANISM; DYSPAREUNIA; ESTROGEN ACTIVITY; ESTROGEN DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; LIBIDO; MEMORY; MOOD; POSTMENOPAUSE; PSYCHOLOGICAL ASPECT; SEXUAL FUNCTION; SOCIAL ASPECT; VAGINA DISEASE; WELLBEING;

EID: 0036253922     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-200205000-00004     Document Type: Article

References (99)

1. Psychiatric morbidity and the menopause; screening of a general population sample
2. Sexuality in the climacteric
3. A longitudinal study of the effects of menopause on sexuality
4. Climacteric complaints in the community
5. Localization of steroid hormone receptors in pelvic muscles
6. A new option for managing urogenital atrophy in postmenopausal women
7. Is sexual life influenced by transdermal estrogen therapy? A double blind placebo controlled study in postmenopausal women
8. Androgen replacement in women: A commentary
9. Sex steroids and bone density in premenopausal and perimenopausal women
10. Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri- and postmenopausal women
11. The role of local estrogen biosynthesis in males and females
12. Estradiol and testosterone in specific regions of the human female brain in different endocrine states
13. Aromatase activity in the rat brain: Hormone regulation and sex differences
14. Survival of reproductive behaviours in estrogen receptor beta gene-deficient male and female mice
15. Characterization of the fertility of male aromatase knockout mice
16. Preoptic formation of 17B oestradiol is influenced by behavioural stimuli in the dove
17. Gender differences in behaviour: Activating effects of cross-sex hormones
18. The psychoendocrinology of female sexuality
19. Steroid and gonadotropin levels in women during the peri-menopausal years
20. Twenty-four hour mean plasma testosterone concentration declines with age in normal premenopausal women
21. Evidence for diminished midcycle ovarian androgen production in older reproductive aged women
22. Adrenal and gonadal androgen secretion in normal females
23. Marked decline in serum concentrations of adrenal C 19 sex steroid precursors and conjugated androgen metaboliltes during aging
24. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer
25. Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause
26. Psychological reactions and sexual life after hysterectomy with and without oophorectomy
27. Estrogens in the causation of breast, endometrial and ovarian cancers: Evidence and hypotheses from epidemiological findings
28. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
29. Serum estradiol binding profiles in postmenopausal women undergoing three common estrogen replacement therapies
30. Markedly elevated levels of estrone sulfate after long term oral, but not transdermal, administration of estradiol in postmenopausal women
31. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and post-menopausal breast cancer patients
32. Effect of hormone replacement therapy on breast cancer risk; Estrogen versus estrogen plus progestin
33. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
34. A longitudinal study of the perimenopausal transition: Altered profiles of steroid and pituitary hormones, SHBG and bone mineral density
35. The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women
36. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogenonly therapy: Sexual behaviour and neuroendocrine response
37. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy
38. Intracrinology: The secret of the tissue-specificity of tibolone
39. Tibolone: A steroid with tissue-specific mode of action
40. Placebo controlled cross over study of effects of Org OD 14 in menopausal women
41. A comparative study of two hormone replacement regimens on safety and efficacy variables
42. Livial: A review of clinical studies
43. Clinical profile of Org OD 14
44. Differential effects of the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy
45. The effects of tibolone on proliferation, differentiation and apoptosis in human breast cells
46. A double blind randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms
47. Mammographic density in postmenopausal women treated with tibolone, estriol or conventional hormone replacement therapy
48. Climacteric symptoms in healthy middle aged women
49. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause
50. Bioavailable testosterone and depressed mood in older men: The Rancho Bernardo Study
51. Salivary testosterone levels and major depressive illness in men
52. Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men
53. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women
54. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric
55. Subcutaneous hormone implants for the control of climacteric symptoms
56. The psychological general well-being (PGWB) index
57. Effects of Org OD 14 on pituitary and peripheral beta-endorphin in castrated rats and post-menopausal women
58. Opiod peptides
59. Progesterone receptors and dopamine receptors are required in delta9-tetrahydrocannabinol modulation of sexual receptivity in female rats
60. Different patterns of central and peripheral beta EP, beta LPH and ACTH throughout life
61. Effect of gonadectomy and gonadal steroid replacement on pituitary and plasma beta-endorphin levels in the rat
62. Steroid replacement increases beta-endorphin and betalipotropin plasma levels in postmenopausal women
63. Beta-endorphin in the male rat pituitary: Testosterone influences the effects of cocaine
64. Elevated levels of plasma beta-endorphin in a group of women with polycystic ovarian disease
65. The use of analogue scales in rating subjective feelings
66. Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints
67. Treatment of climacteric complaints with OrgOD14: A comparative study with estradiol valerate and placebo
68. The women's health questionnaire: A measure of mid-aged women's perceptions of their emotional and physical health
69. A clinical scale for the self assessment of irritability
70. The effect of tibolone versus continuous combined norethisterone acetate and oestradiol on memory, libido and mood of postmenopausal women: A pilot study
71. "Add back" estrogen reverses cognitive deficits induced by gonadotropin-releasing hormone antagonist in women with leiomyomata uteri
72. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia
73. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: A randomized controlled trial
74. Estrogen for Alzheimer's disease in women: Randomized double-blind placebo-controlled trial
75. Cognitive decline in women in relation to non-protein-bound oestradiol concentrations
76. Estrogen use and verbal memory in post-menopausal women
77. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks
78. Steroid hormone, the menopause, sexuality and well-being of women
79. Sexuality and the menopause
80. Hormones and sexuality in postmenopausal women: A psychophysiological study
81. Sexuality, hormones and the menopausal transition
82. Sex differences in the 24 hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults
83. Androgen enhances sexual motivation in females: A prospective, crossover study of sex steroid administration in surgical menopause
84. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: The Rancho Bernardo Study
85. Effect of combined implants of estradiol and testosterone on libido in postmenopausal women
86. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality
87. Changes in sex behaviour after menopause: Effects of tibolone
88. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women
89. Effect on sexual life-a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen
90. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women
91. Selective influence of menstrual cycle on perception of stimuli with reproductive significance
92. The importance of sexual activity and hormones
93. Effects of estrogen therapy on vaginal physiology during menopause
94. Time course of effects of testosterone administration on sexual arousal in women
95. Vasodilator effects of estrogen are not diminished by androgen in postmenopausal women
96. Vaginal ultrasound of the nedometrium in postmenopausal women with symptoms of urogenital atrophy on low dose oestrogen or tibolone treatment: A comparison
97. Long term effects of tibolone on the genital tract in postmenopausal women
98. Tibolone prevents atherosclerotic lesion formation in cholesterol fed rabbits
99. Tibolone inhibits leucocyte adhesion molecule expression in human endothelial cells